http://www.biotechnologynews.net/storyview.asp?storyid=1026042§ionsource=s0&highlight=%NOVOGEN%
MORE NEWS!
NOVOGEN dumps phase 3 trial of "OVERTURE" Ovarian cancer therapy ( oral )on April 14th. Pure coincidence? I dont think so.
Adds substantial weight to the PRR technology efficacy me thinks!. Those in the know ( industry ) know!
The only question is how will PRR's management handle the new leverage coming thier way
http://www.biotechnologynews.net/storyview.asp?storyid=1026042&se...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |